WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma

被引：0
|
作者：
Nicholas Coupe
Lina Guo
Esther Bridges
Leticia Campo
Olivia Espinosa
Richard Colling
Andrea Marshall
Ashwin Nandakumar
Ruud van Stiphout
Francesca M. Buffa
Pippa G. Corrie
Mark R. Middleton
Valentine M. Macaulay
机构：
[1] University of Oxford,Department of Oncology
[2] Oxford University Hospitals NHS Foundation Trust,Department of Oncology, Oxford Cancer and Haematology Centre
[3] Churchill Hospital,Department of Cellular Pathology
[4] Oxford University Hospitals NHS Foundation Trust,Warwick Clinical Trials Unit, Division of Health Sciences
[5] John Radcliffe Hospital,Nuffield Department of Surgical Sciences
[6] University of Warwick,Department of Oncology
[7] University of Oxford,undefined
[8] Cambridge University Hospitals NHS Foundation Trust,undefined
[9] Addenbrooke’s Hospital,undefined
来源：
Cellular Oncology | 2023年 / 46卷
关键词：
Melanoma; BRAF; Bevacizumab; ROR2; WNT5A;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：391 / 407
页数：16
相关论文
共 50 条
  • [1] WNT5A-ROR2 axis mediates VEGF dependence of BRAF mutant melanoma
    Coupe, Nicholas
    Guo, Lina
    Bridges, Esther
    Campo, Leticia
    Espinosa, Olivia
    Colling, Richard
    Marshall, Andrea
    Nandakumar, Ashwin
    van Stiphout, Ruud
    Buffa, Francesca M.
    Corrie, Pippa G.
    Middleton, Mark R.
    Macaulay, Valentine M.
    CELLULAR ONCOLOGY, 2023, 46 (02) : 391 - 407
  • [2] The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
    M P O’Connell
    J L Fiori
    M Xu
    A D Carter
    B P Frank
    T C Camilli
    A D French
    S K Dissanayake
    F E Indig
    M Bernier
    D D Taub
    S M Hewitt
    A T Weeraratna
    Oncogene, 2010, 29 : 34 - 44
  • [3] The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
    O'Connell, M. P.
    Fiori, J. L.
    Xu, M.
    Carter, A. D.
    Frank, B. P.
    Camilli, T. C.
    French, A. D.
    Dissanayake, S. K.
    Indig, F. E.
    Bernier, M.
    Taub, D. D.
    Hewitt, S. M.
    Weeraratna, A. T.
    ONCOGENE, 2010, 29 (01) : 34 - 44
  • [4] IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma
    Patel, Hima
    Mishra, Rosalin
    Yacoub, Nour
    Alanazi, Samar
    Kilroy, Mary Kate
    Garrett, Joan T.
    CANCERS, 2021, 13 (22)
  • [5] WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3
    Arabzadeh, Somayeh
    Hossein, Ghamartaj
    Salehi-Dulabi, Zahra
    Zarnani, Amir Hassan
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2016, 21
  • [6] BRAF Mutant Melanoma Adjusts to BRAF/MEK Inhibitors via Dependence on Increased Antioxidant SOD2 and Increased Reactive Oxygen Species Levels
    Yuan, Long
    Mishra, Rosalin
    Patel, Hima
    Alanazi, Samar
    Wei, Xin
    Ma, Zhijun
    Garrett, Joan T.
    CANCERS, 2020, 12 (06) : 1 - 14
  • [7] SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
    Loria, Rossella
    Laquintana, Valentina
    Scalera, Stefano
    Fraioli, Rocco
    Caprara, Valentina
    Falcone, Italia
    Bazzichetto, Chiara
    Di Martile, Marta
    Rosano, Laura
    Del Bufalo, Donatella
    Bossi, Gianluca
    Sperduti, Isabella
    Terrenato, Irene
    Visca, Paolo
    Soddu, Silvia
    Milella, Michele
    Ciliberto, Gennaro
    Falcioni, Rita
    Ferraresi, Virginia
    Bon, Giulia
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [8] SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
    Rossella Loria
    Valentina Laquintana
    Stefano Scalera
    Rocco Fraioli
    Valentina Caprara
    Italia Falcone
    Chiara Bazzichetto
    Marta Di Martile
    Laura Rosanò
    Donatella Del Bufalo
    Gianluca Bossi
    Isabella Sperduti
    Irene Terrenato
    Paolo Visca
    Silvia Soddu
    Michele Milella
    Gennaro Ciliberto
    Rita Falcioni
    Virginia Ferraresi
    Giulia Bon
    Journal of Experimental & Clinical Cancer Research, 41
  • [9] Punicalagin ameliorates lipopolysaccharide-induced inflammatory response in dental pulp cells via inhibition of the NF-κB/Wnt5a-ROR2 pathway
    Yang, Yumeng
    Deng, Ke
    Jiang, Shan
    Guo, Xiaolan
    Zhong, Yiming
    Wu, Buling
    Wei, Liu
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2025,
  • [10] Regulating the response to targeted MEK inhibition in melanoma Enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt/β-catenin activation
    Conrad, William H.
    Swift, Reyna D.
    Biechele, Travis L.
    Kulikauskas, Rima M.
    Moon, Randall T.
    Chien, Andy J.
    CELL CYCLE, 2012, 11 (20) : 3724 - 3730
12345